MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2023

Type / Class
Equity / Common Stock, $0.00000002 par value
Symbol
MEIP on Nasdaq
Shares outstanding
29,545,622
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 3.7% 1,093,188 Anson Funds Management LP 22 Jul 2025

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$957,995 0
2023 Q2 145,654 $958,000 -$25,679,278 $6.58 1
2023 Q1 48,845,759 $11,179,346 -$894,257 $0.23 45
2022 Q4 49,470,694 $12,049,333 -$2,451,067 $0.24 44
2022 Q3 47,607,776 $18,402,998 -$82,394 $0.39 55
2022 Q2 45,552,286 $27,545,104 -$2,436,831 $0.60 56
2022 Q1 48,590,325 $29,271,440 -$85,537,409 $0.60 82
2021 Q4 89,035,112 $237,608,275 +$60,969,062 $2.67 101
2021 Q3 65,076,098 $179,625,137 -$10,717,534 $2.76 101
2021 Q2 68,171,058 $194,371,475 -$6,378,620 $2.85 106
2021 Q1 70,784,540 $242,767,740 +$18,948,500 $3.43 105
2020 Q4 63,741,892 $168,370,331 -$2,937,168 $2.64 100
2020 Q3 65,335,503 $203,852,307 +$6,905,611 $3.12 99
2020 Q2 62,875,358 $259,680,491 +$1,474,963 $4.13 100
2020 Q1 64,221,880 $102,999,509 +$22,258,206 $1.61 75
2019 Q4 49,078,070 $121,713,810 +$24,164,999 $2.48 74
2019 Q3 36,831,719 $61,876,463 -$21,545,748 $1.68 66
2019 Q2 45,776,780 $114,440,440 +$11,771,388 $2.50 68
2019 Q1 41,010,769 $125,904,000 +$2,372,409 $3.07 62
2018 Q4 39,633,402 $104,633,000 +$7,193,764 $2.64 54
2018 Q3 36,164,953 $155,550,322 -$1,644,942 $4.31 59
2018 Q2 36,391,138 $143,378,000 +$111,591,902 $3.94 57
2018 Q1 8,480,866 $17,557,000 -$483,481 $2.07 41
2017 Q4 8,711,384 $18,268,000 -$178,089 $2.10 45
2017 Q3 8,602,744 $23,066,000 +$5,881,409 $2.68 52
2017 Q2 6,515,002 $15,567,000 +$1,002,011 $2.39 43
2017 Q1 6,300,990 $10,206,000 +$579,254 $1.62 41
2016 Q4 6,476,715 $9,324,000 +$440,613 $1.44 32
2016 Q3 5,522,709 $9,719,000 -$2,410,699 $1.76 36
2016 Q2 7,621,766 $10,361,000 -$3,092,136 $1.36 31
2016 Q1 9,929,185 $12,511,000 +$612,639 $1.26 34
2015 Q4 6,600,579 $10,561,000 +$592,486 $1.60 37
2015 Q3 6,217,539 $9,759,657 +$1,987,275 $1.57 33
2015 Q2 4,892,607 $8,366,000 -$5,311,451 $1.71 35
2015 Q1 7,979,253 $14,284,000 -$53,085,440 $1.79 41
2014 Q4 22,694,381 $96,924,463 +$35,679,034 $4.27 48
2014 Q3 12,032,981 $83,027,000 -$3,244,733 $6.90 34
2014 Q2 13,292,012 $84,269,801 -$14,971,805 $6.34 40
2014 Q1 13,970,657 $155,496,299 +$18,572,610 $11.13 46